Cargando…
Development of second primary cancer in Korean breast cancer survivors
PURPOSE: Breast cancer survivors have slightly increased the risk of second primary cancers. Breast, colon, uterine, and ovarian cancers are common secondary cancers in breast cancer survivors. In this study, we assessed the development of second primary cancers of breast cancer survivors in Korea....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729121/ https://www.ncbi.nlm.nih.gov/pubmed/29250506 http://dx.doi.org/10.4174/astr.2017.93.6.287 |
_version_ | 1783286134038593536 |
---|---|
author | Jung, Hong Kyu Park, Suyeon Kim, Nam Won Lee, Jong Eun Kim, Zisun Han, Sun Wook Hur, Sung Mo Kim, Sung Young Lim, Cheol Wan Lee, Min Hyuk Lee, Jihyoun |
author_facet | Jung, Hong Kyu Park, Suyeon Kim, Nam Won Lee, Jong Eun Kim, Zisun Han, Sun Wook Hur, Sung Mo Kim, Sung Young Lim, Cheol Wan Lee, Min Hyuk Lee, Jihyoun |
author_sort | Jung, Hong Kyu |
collection | PubMed |
description | PURPOSE: Breast cancer survivors have slightly increased the risk of second primary cancers. Breast, colon, uterine, and ovarian cancers are common secondary cancers in breast cancer survivors. In this study, we assessed the development of second primary cancers of breast cancer survivors in Korea. METHODS: Medical records of patients with breast cancer in 3 tertiary medical institutions were reviewed retrospectively. We evaluated secondary malignancy diagnosed at least 2 months after the breast cancer diagnosis. Based on the International Classification of Disease-9 codes of malignancies, secondary primary breast cancer records were evaluated with person-year adjustment. The standardized incidence ratio (SIR) was assessed using national cancer incidence. RESULTS: A total of 3,444 treatment records were included from 3 medical centers. The cumulative incidence of overall second primary cancers was 2.8% (n = 93). The SIR was significantly higher in all sites (1.56; 95% confidence interval [CI], 1.26–1.91), endometrial cancer (5.65; 95% CI, 2.06–12.31), biliary tract cancer (3.96; 95% CI, 1.19–8.60), and thyroid cancer (2.29; 95% CI, 1.67–3.08). CONCLUSION: The incidence of cancer was higher in breast cancer survivors compared to general population. Surveillance of secondary cancer in this group should be recommended individually considering the benefit related to the prognosis of primary breast cancer. |
format | Online Article Text |
id | pubmed-5729121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Surgical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-57291212017-12-15 Development of second primary cancer in Korean breast cancer survivors Jung, Hong Kyu Park, Suyeon Kim, Nam Won Lee, Jong Eun Kim, Zisun Han, Sun Wook Hur, Sung Mo Kim, Sung Young Lim, Cheol Wan Lee, Min Hyuk Lee, Jihyoun Ann Surg Treat Res Original Article PURPOSE: Breast cancer survivors have slightly increased the risk of second primary cancers. Breast, colon, uterine, and ovarian cancers are common secondary cancers in breast cancer survivors. In this study, we assessed the development of second primary cancers of breast cancer survivors in Korea. METHODS: Medical records of patients with breast cancer in 3 tertiary medical institutions were reviewed retrospectively. We evaluated secondary malignancy diagnosed at least 2 months after the breast cancer diagnosis. Based on the International Classification of Disease-9 codes of malignancies, secondary primary breast cancer records were evaluated with person-year adjustment. The standardized incidence ratio (SIR) was assessed using national cancer incidence. RESULTS: A total of 3,444 treatment records were included from 3 medical centers. The cumulative incidence of overall second primary cancers was 2.8% (n = 93). The SIR was significantly higher in all sites (1.56; 95% confidence interval [CI], 1.26–1.91), endometrial cancer (5.65; 95% CI, 2.06–12.31), biliary tract cancer (3.96; 95% CI, 1.19–8.60), and thyroid cancer (2.29; 95% CI, 1.67–3.08). CONCLUSION: The incidence of cancer was higher in breast cancer survivors compared to general population. Surveillance of secondary cancer in this group should be recommended individually considering the benefit related to the prognosis of primary breast cancer. The Korean Surgical Society 2017-12 2017-12-01 /pmc/articles/PMC5729121/ /pubmed/29250506 http://dx.doi.org/10.4174/astr.2017.93.6.287 Text en Copyright © 2017, the Korean Surgical Society http://creativecommons.org/licenses/by-nc/4.0/ Annals of Surgical Treatment and Research is an Open Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Jung, Hong Kyu Park, Suyeon Kim, Nam Won Lee, Jong Eun Kim, Zisun Han, Sun Wook Hur, Sung Mo Kim, Sung Young Lim, Cheol Wan Lee, Min Hyuk Lee, Jihyoun Development of second primary cancer in Korean breast cancer survivors |
title | Development of second primary cancer in Korean breast cancer survivors |
title_full | Development of second primary cancer in Korean breast cancer survivors |
title_fullStr | Development of second primary cancer in Korean breast cancer survivors |
title_full_unstemmed | Development of second primary cancer in Korean breast cancer survivors |
title_short | Development of second primary cancer in Korean breast cancer survivors |
title_sort | development of second primary cancer in korean breast cancer survivors |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729121/ https://www.ncbi.nlm.nih.gov/pubmed/29250506 http://dx.doi.org/10.4174/astr.2017.93.6.287 |
work_keys_str_mv | AT junghongkyu developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT parksuyeon developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT kimnamwon developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT leejongeun developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT kimzisun developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT hansunwook developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT hursungmo developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT kimsungyoung developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT limcheolwan developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT leeminhyuk developmentofsecondprimarycancerinkoreanbreastcancersurvivors AT leejihyoun developmentofsecondprimarycancerinkoreanbreastcancersurvivors |